A Phase I Clinical Trial of Recombinant Herpes Zoster Vaccine (CHO Cell)
Clinical trial NCT07633197 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07633197
- Sponsor
- Changchun BCHT Biotechnology Co.
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-28
- Primary completion
- 2026-12-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.